Connection
Stephen Waldo to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Stephen Waldo has written about Adrenergic beta-Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.064 |
|
|
|
-
Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Bar?n AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
Score: 0.035
-
Chen DC, Singh GD, Armstrong EJ, Waldo SW, Laird JR, Amsterdam EA. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease. Am J Cardiol. 2017 Apr 15; 119(8):1146-1152.
Score: 0.029